Cargando…

SARS-CoV-2 in Malaysia: A surge of reinfection during the predominantly Omicron period

Detalles Bibliográficos
Autores principales:	Yang, Su Lan, Teh, Hoon Shien, Suah, Jing Lian, Husin, Masliyana, Hwong, Wen Yea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417595/ https://www.ncbi.nlm.nih.gov/pubmed/36060536 http://dx.doi.org/10.1016/j.lanwpc.2022.100572

Ejemplares similares

Translation and Validation of the Questionnaire on Acceptance to Telemedicine from the Technology Acceptance Model (TAM) for Use in Malaysia
por: Husin, Masliyana, et al.
Publicado: (2022)

SARS-CoV-2 spread and hospitalisations in paediatric patients during the omicron surge
por: Belay, Ermias D, et al.
Publicado: (2022)

Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in Malaysia
por: Husin, Masliyana, et al.
Publicado: (2022)

Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection
por: Suah, Jing Lian, et al.
Publicado: (2022)

Quality of hypertension management in public primary care clinics in Malaysia: An update
por: Teh, Xin Rou, et al.
Publicado: (2020)

Risk of SARS-CoV-2 reinfection after natural infection
por: Boyton, Rosemary J, et al.
Publicado: (2021)

SARS-Cov-2 immune waning and reinfection in care-home settings
por: Altmann, Daniel M, et al.
Publicado: (2021)

Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico
por: Montes-González, José Antonio, et al.
Publicado: (2023)

Assessing the Availability of Teleconsultation and the Extent of Its Use in Malaysian Public Primary Care Clinics: Cross-sectional Study
por: Ng, Sock Wen, et al.
Publicado: (2022)

SARS-CoV-2 reinfection in a closed setting: lessons for the community
por: Velasco, María, et al.
Publicado: (2021)

Immunity Acquired From the First Wave of COVID-19 Against Reinfections Up to Omicron Predominance
por: Lan, Fan-Yun, et al.
Publicado: (2023)

The S-Trimer (SCB-2019) COVID-19 vaccine and reinfection with SARS-CoV-2
por: Li, Jing-Xin, et al.
Publicado: (2022)

SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period
por: Boekel, Laura, et al.
Publicado: (2022)

What reinfections mean for COVID-19
por: Iwasaki, Akiko
Publicado: (2021)

A Small Surge in Incidence of SARS-CoV-2 Omicron Variant in the “Dynamic Zero” Period
por: Li, Xiaona, et al.
Publicado: (2023)

COVID-19 infection, reinfection, and the transition to endemicity
por: Cohen, Cheryl, et al.
Publicado: (2023)

Two individuals with potential monkeypox virus reinfection
por: Raccagni, Angelo Roberto, et al.
Publicado: (2023)

Imprinted hybrid immunity against XBB reinfection
por: Boyton, Rosemary J, et al.
Publicado: (2023)

Importance of understanding the reinfection risk of COVID-19 in children
por: Crawford, Nigel W
Publicado: (2022)

Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study
por: Suah, Jing Lian, et al.
Publicado: (2022)

Determinants of reinfection with SARS-CoV-2 Omicron variant
por: Bisharat, N., et al.
Publicado: (2023)

Pathogenicity of SARS-CoV-2 Omicron BA.1.1 in hamsters
por: Chan, Jasper Fuk-Woo, et al.
Publicado: (2022)

Estimating disease severity of Omicron and Delta SARS-CoV-2 infections
por: Sigal, Alex, et al.
Publicado: (2022)

Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
por: Nadesalingam, Angalee, et al.
Publicado: (2023)

The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
por: Boaventura, Viviane S, et al.
Publicado: (2023)

Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
por: Vasin, Andrey V, et al.
Publicado: (2023)

High rate of reinfection with the SARS-CoV-2 Omicron variant
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Reinfections with Different SARS-CoV-2 Omicron Subvariants, France
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

SARS-CoV-2 reinfections during the Delta and Omicron waves
por: Morris, C. Paul, et al.
Publicado: (2022)

The emerging antimicrobial resistance crisis during the COVID-19 surge in China
por: Wang, Zhicheng, et al.
Publicado: (2023)

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
por: Karim, Salim S Abdool, et al.
Publicado: (2021)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

Omicron severity: milder but not mild
por: Nealon, Joshua, et al.
Publicado: (2022)

Smart toilets for monitoring COVID-19 surges: passive diagnostics and public health
por: Ge, T. Jessie, et al.
Publicado: (2022)

PICK-ing Malaysia’s Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine Portfolio
por: Suah, Jing Lian, et al.
Publicado: (2021)

New year, new SARS-CoV-2 variant: Resolutions on genomic surveillance protocols to face Omicron
por: Oróstica, Karen Y., et al.
Publicado: (2022)

Rate of SARS-CoV-2 Reinfection During an Omicron Wave in Iceland
por: Eythorsson, Elias, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
por: Goga, Ameena, et al.
Publicado: (2022)

Omicron in pregnancy: time to breathe easier?
por: Auger, Nathalie, et al.
Publicado: (2022)

Genomic evidence for reinfection with different Omicron subvariants
por: Hirotsu, Yosuke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4uoe4krhv8m3hag4bmgt0gmakq